| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.01500-06 |
| P8608 | Fatcat ID | release_dliu37llmfbcbnfkvyy5b52apa |
| P932 | PMC publication ID | 1891410 |
| P698 | PubMed publication ID | 17387154 |
| P5875 | ResearchGate publication ID | 6420739 |
| P50 | author | Alfonso Soler-Bistué | Q57407900 |
| P2093 | author name string | Angeles Zorreguieta | |
| Marcelo E Tolmasky | |||
| Michelle Don | |||
| Renee Sarno | |||
| Hongphuc Ha | |||
| Alfonso J C Soler Bistué | |||
| P2860 | cites work | Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes. | Q52021317 |
| Inactivation of gene expression using ribonuclease P and external guide sequences. | Q52172558 | ||
| Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. | Q53733868 | ||
| Nuclease-resistant external guide sequence-induced cleavage of target RNA by human ribonuclease P. | Q54115674 | ||
| External Guide Sequences for an RNA Enzyme | Q54709972 | ||
| Protein-RNA interactions in the RNase P holoenzyme from Escherichia coli | Q69042546 | ||
| Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides | Q74613056 | ||
| Use of T7 RNA polymerase to direct expression of cloned genes | Q27860692 | ||
| Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance | Q28138065 | ||
| A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes | Q29547324 | ||
| Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. | Q30325785 | ||
| The CTX-M beta-lactamase pandemic. | Q30356558 | ||
| Discovery of non-carbohydrate inhibitors of aminoglycoside-modifying enzymes | Q33222759 | ||
| Artificial regulation of gene expression in Escherichia coli by RNase P. | Q33757612 | ||
| Bacterial resistance to aminoglycosides and beta-lactams: the Tn1331 transposon paradigm | Q33854074 | ||
| Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase | Q33935293 | ||
| Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection | Q33938093 | ||
| Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1. | Q34142178 | ||
| RNase P: variations and uses | Q34462159 | ||
| Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA. | Q34510638 | ||
| Combinatorial genetic evolution of multiresistance | Q34561908 | ||
| Vibrio cholerae InV117, a class 1 integron harboring aac(6')-Ib and blaCTX-M-2, is linked to transposition genes. | Q34648755 | ||
| Antisense technologies. Improvement through novel chemical modifications | Q35106663 | ||
| Versatility of aminoglycosides and prospects for their future | Q35176271 | ||
| Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis | Q35573551 | ||
| Sublethal concentrations of the aminoglycoside amikacin interfere with cell division without affecting chromosome dynamics | Q35635646 | ||
| Molecular insights into aminoglycoside action and resistance | Q36034615 | ||
| Inhibition of Aminoglycoside 6′- N -Acetyltransferase Type Ib-Mediated Amikacin Resistance by Antisense Oligodeoxynucleotides | Q36048468 | ||
| Molecular targets for design of novel inhibitors to circumvent aminoglycoside resistance | Q36109016 | ||
| Inhibition of Escherichia coli viability by external guide sequences complementary to two essential genes | Q36228809 | ||
| Phenotypic conversion of drug-resistant bacteria to drug sensitivity | Q36543088 | ||
| Bacterial RNase P: a new view of an ancient enzyme | Q36596477 | ||
| Targeted cleavage of mRNA in vitro by RNase P from Escherichia coli | Q36942383 | ||
| Targeted cleavage of mRNA by human RNase P | Q37173898 | ||
| Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli | Q38294079 | ||
| Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs | Q39785439 | ||
| Transposon-mediated amikacin resistance in Klebsiella pneumoniae | Q39832338 | ||
| Disruption of type III secretion in Salmonella enterica serovar Typhimurium by external guide sequences | Q40592634 | ||
| RNase P from bacteria. Substrate recognition and function of the protein subunit | Q41196311 | ||
| In117, an unusual In0-like class 1 integron containing CR1 and bla(CTX-M-2) and associated with a Tn21-like element | Q42112520 | ||
| Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece. | Q44213060 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amikacin | Q408529 |
| P304 | page(s) | 1918-1925 | |
| P577 | publication date | 2007-03-26 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | External guide sequences targeting the aac(6')-Ib mRNA induce inhibition of amikacin resistance | |
| P478 | volume | 51 |
| Q52744431 | Amikacin: Uses, Resistance, and Prospects for Inhibition. |
| Q34354185 | Aminoglycoside modifying enzymes |
| Q96302336 | Antisense Antibacterial Compounds |
| Q88786417 | Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes |
| Q92989276 | Bridged Nucleic Acids Reloaded |
| Q36143151 | External guide sequence technology: a path to development of novel antimicrobial therapeutics |
| Q28756986 | Hitting bacteria at the heart of the central dogma: sequence-specific inhibition |
| Q57817509 | Identification of the Ribonuclease P Catalytic Subunit: Cleavage of a Target mRNA in the Presence of an External Guide Sequence |
| Q37208638 | Inactivation of expression of several genes in a variety of bacterial species by EGS technology |
| Q37304179 | Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria |
| Q34460507 | Inhibition of cell division induced by external guide sequences (EGS Technology) targeting ftsZ |
| Q33384124 | Inhibition of expression in Escherichia coli of a virulence regulator MglB of Francisella tularensis using external guide sequence technology |
| Q37704699 | Inhibition of gene expression by RNase P. |
| Q34980567 | Inhibitors of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] identified by in silico molecular docking |
| Q38633823 | RNase P-Mediated Sequence-Specific Cleavage of RNA by Engineered External Guide Sequences |
| Q36497230 | Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences |
| Q36850490 | Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm |
| Q26859978 | Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections |
| Q37323966 | Tackling antibiotic resistance: a dose of common antisense? |
| Q37528001 | Understanding and overcoming aminoglycoside resistance caused by N-6'-acetyltransferase |
Search more.